Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 600 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$13.83M
Operating Margin
-859.22%
TTM Avg
-477.88%
3Y Avg
-341.34%
5Y Avg
-316.87%
Market Cap
$13.34M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$14.00M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$14.47M
Operating Margin
-56.17%
TTM Avg
-72.17%
3Y Avg
-80.90%
5Y Avg
-88.24%
Market Cap
$12.61M
Operating Margin
-1315.51%
TTM Avg
-120503.86%
3Y Avg
-60605.86%
5Y Avg
-40403.91%
Market Cap
$12.41M
Operating Margin
-5.39%
TTM Avg
-4.88%
3Y Avg
-13.74%
5Y Avg
-13.69%
Market Cap
$15.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-4987.62%
Market Cap
$12.00M
Operating Margin
-33.37%
TTM Avg
-42.32%
3Y Avg
-69.57%
5Y Avg
-60.22%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IN8bio, Inc. (INAB) | $13.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vyome Holdings, Inc. (HIND)vs › | $13.83M | -859.22% | -477.88% | -341.34% | -316.87% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.47M | -56.17% | -72.17% | -80.90% | -88.24% |
| Dare Bioscience, Inc. (DARE)vs › | $12.61M | -1315.51% | -120503.86% | -60605.86% | -40403.91% |
| IRIDEX Corporation (IRIX)vs › | $12.41M | -5.39% | -4.88% | -13.74% | -13.69% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | 0.00% | 0.00% | 0.00% | -4987.62% |
| Cytosorbents Corporation (CTSO)vs › | $12.00M | -33.37% | -42.32% | -69.57% | -60.22% |
| Lantern Pharma Inc. (LTRN)vs › | $11.81M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
